TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.
Jiang G, Wang X, Zhou Y, Zou C, Wang L, Wang W, Zhang D, Xu H, Li J, Li F, Luo D, Ma X, Ma D, Tan S, Wei R, Xi L.
Jiang G, et al. Among authors: wang x, wang w, wang l.
Int J Nanomedicine. 2021 Jun 15;16:4087-4104. doi: 10.2147/IJN.S298252. eCollection 2021.
Int J Nanomedicine. 2021.
PMID: 34163161
Free PMC article.